OSAM
MEDP icon

O'Shaughnessy Asset Management’s Medpace MEDP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$867K Sell
1,637
-137
-8% -$63.2K ﹤0.01% 1329
2026
Q1 		$852K Sell
1,774
-10
-0.6% -$5.12K ﹤0.01% 1264
2025
Q4 		$1M Buy
1,784
+384
+27% +$218K 0.01% 1149
2025
Q3 		$720K Buy
1,400
+325
+30% +$142K ﹤0.01% 1290
2025
Q2 		$337K Sell
1,075
-270
-20% -$81.1K ﹤0.01% 1571
2025
Q1 		$410K Buy
1,345
+425
+46% +$143K ﹤0.01% 1419
2024
Q4 		$306K Sell
920
-213
-19% -$72.2K ﹤0.01% 1518
2024
Q3 		$401K Buy
1,133
+63
+6% +$23.9K ﹤0.01% 1329
2024
Q2 		$441K Buy
1,070
+310
+41% +$123K ﹤0.01% 1182
2024
Q1 		$307K Buy
+760
New +$267K ﹤0.01% 1306
2023
Q3 		– Sell
-1,704
Closed -$409K – 1658
2023
Q2 		$409K Sell
1,704
-229
-12% -$47.6K 0.01% 957
2023
Q1 		$364K Sell
1,933
-23
-1% -$4.76K 0.01% 981
2022
Q4 		$415K Sell
1,956
-768
-28% -$153K 0.01% 853
2022
Q3 		$428K Buy
2,724
+180
+7% +$28.7K 0.01% 795
2022
Q2 		$381K Sell
2,544
-9
-0.4% -$1.3K 0.01% 771
2022
Q1 		$418K Sell
2,553
-67
-3% -$11K 0.01% 777
2021
Q4 		$570K Sell
2,620
-1,110
-30% -$232K 0.01% 661
2021
Q3 		$707K Sell
3,730
-629
-14% -$115K 0.01% 569
2021
Q2 		$770K Sell
4,359
-1,186
-21% -$205K 0.02% 544
2021
Q1 		$909K Sell
5,545
-2,077
-27% -$318K 0.02% 427
2020
Q4 		$1.06M Sell
7,622
-219
-3% -$27.6K 0.03% 344
2020
Q3 		$878K Buy
7,841
+1,269
+19% +$147K 0.03% 320
2020
Q2 		$612K Buy
6,572
+907
+16% +$77.2K 0.02% 360
2020
Q1 		$417K Buy
5,665
+249
+5% +$21.6K 0.01% 319
2019
Q4 		$455K Buy
5,416
+2,644
+95% +$205K 0.01% 420
2019
Q3 		$233K Buy
2,772
+1,719
+163% +$130K 0.01% 507
2019
Q2 		$69K Buy
1,053
+39
+4% +$2.25K ﹤0.01% 695
2019
Q1 		$60K Hold
1,014
– – ﹤0.01% 710
2018
Q4 		$54K Hold
1,014
– – ﹤0.01% 701
2018
Q3 		$60K Buy
+1,014
New +$55.5K ﹤0.01% 701

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

O'Shaughnessy Asset Management's MEDP Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Medpace (MEDP) stake by 7.7% in Q2 2026, selling an estimated $63.2K and leaving 1,637 shares worth $867K. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

O'Shaughnessy Asset Management first reported a position in MEDP in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.06M in Q4 2020. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • O'Shaughnessy Asset Management held 1,637 shares of Medpace worth $867K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 137 Medpace shares in Q2 2026, an estimated $63.2K.
  • Medpace made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1329 holding.
  • O'Shaughnessy Asset Management first reported a position in Medpace in Q3 2018 and has held it in 30 quarters since.
  • O'Shaughnessy Asset Management's Medpace position peaked at $1.06M in Q4 2020.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.